课题基金 / 基金详情

TRANSFORMING DOMAINS IN THE IGF-1 RECEPTOR

TRANSFORMING DOMAINS IN THE IGF-1 RECEPTOR
转变 IGF-1 受体中的结构域
批准号:
2330952
负责人:
CHRISTIAN SELL
金额:
$11.15万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-02-06 至 2000-01-31

项目摘要

项目成果

CHRISTIAN SELL的其他基金

相似基金

相关文献

中文摘要
翻译
我们已经从小鼠胚胎中获得了纯合的细胞系,用于靶向 胰岛素样生长因子1型受体(IGF-1R)的破坏 Gen(Lui等人)1993年,Baker等人提出的。1993年)。这些IGF-1的细胞系 R基因敲除小鼠和野生型窝产仔(分别为R-和W) 它们的增长和转型的相对容易程度是不同的。R细胞, 与W细胞不同的是,在无血清培养中不会发生细胞分裂 补充PDGF、EGF、IGF-1,不能通过 介绍猴病毒40(SV4O)大T抗原。R细胞 表达SV4OT抗原((TSA)R-)保留了 正常成纤维细胞在含血清的培养液中。《重返荒野》 胰岛素样生长因子-1受体进入沙皇细胞后恢复细胞转化能力 SV4OT抗原。初步数据表明,有明显的 由细胞内的IGF-1R产生的信号是专用于 DNA合成或增殖(即进入有丝分裂),以及这些 信号可能与细胞转化所需的信号分开。一个 截短的IGF-1R允许R细胞增殖以响应IGF-1,但 不允许在(TSA)R细胞中转化。为了扩展这些功能, 结果,并检查细胞信号在 我们建议在受体中引入特定的突变,并 在R-和(TSA)R-细胞中表达这些突变受体。的能力 这些突变的受体诱导进入S期,有丝分裂和各种 转变的方面;即焦点形成、锚定独立 生长和致瘤性将被决定。
英文摘要
We have derived cell lines from mouse embryos homozygous for a targeted disruption of the insulin like growth factor type 1 receptor (IGF-1 R) gene (Lui et al. 1993, Baker et al. 1993). The cell lines from these IGF-1 R knockout mice and from wild type littermates (R- and W respectively) differ in their growth and relative ease of transformation. The R- cells, unlike W cells, do not undergo cell division in serum free medium supplemented with PDGF, EGF, IGF-1, and cannot be transformed by the introduction of the simian virus 40 (SV4O) large T antigen. The R- cells expressing the SV4O T antigen ((tsA)R-) retain the characteristics of normal fibroblasts in serum containing medium. Reintroduction of the wild type IGF-1 R into the tsAR- cells restores the transforming capacity of the SV4O T antigen. Preliminary data indicates that there are distinct signals generated by the IGF-1 R within the cell which are specific for DNA synthesis or proliferation (i.e. entry into mitosis) and that these signals may be separate from those needed for cellular transformation. A truncated IGF-1 R allows R-cells to proliferate in response to IGF-1 but does not allow transformation in (tsA)R- cells. In order to extend these results and to examine divergence of cellular signals at the level of the IGF-1 R we propose to introduce specific mutations in the receptor and to express these mutant receptors in R- and (tsA)R- cells. The ability of these mutant receptors to induce entry into S phase, mitosis and various aspects of transformation; i.e. foci formation, anchorage independent growth, and tumorigenicity, will be determined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel longevity enhancing pathways regulated by mTOR
  • 批准号:
    10649541
  • 项目类别:
  • 资助金额:
    $41.39万
  • 财政年份:
    2022
  • 负责人:
    CHRISTIAN SELL
  • 依托单位:
Novel longevity enhancing pathways regulated by mTOR
  • 批准号:
    10446243
  • 项目类别:
  • 资助金额:
    $39.63万
  • 财政年份:
    2022
  • 负责人:
    CHRISTIAN SELL
  • 依托单位:
Novel longevity enhancing pathways regulated by mTOR
  • 批准号:
    10711017
  • 项目类别:
  • 资助金额:
    $38.51万
  • 财政年份:
    2022
  • 负责人:
    CHRISTIAN SELL
  • 依托单位:
Novel longevity enhancing pathways regulated by mTOR
  • 批准号:
    10358671
  • 项目类别:
  • 资助金额:
    $31.05万
  • 财政年份:
    2021
  • 负责人:
    CHRISTIAN SELL
  • 依托单位:
海外基金